Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Current Assets (2018 - 2025)

Historic Current Assets for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $132.8 million.

  • X4 Pharmaceuticals' Current Assets fell 711.12% to $132.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.8 million, marking a year-over-year decrease of 711.12%. This contributed to the annual value of $112.2 million for FY2024, which is 811.05% down from last year.
  • Per X4 Pharmaceuticals' latest filing, its Current Assets stood at $132.8 million for Q3 2025, which was down 711.12% from $72.9 million recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Current Assets ranged from a high of $175.4 million in Q2 2024 and a low of $52.6 million during Q2 2022
  • Over the past 5 years, X4 Pharmaceuticals' median Current Assets value was $101.4 million (recorded in 2021), while the average stood at $108.6 million.
  • Per our database at Business Quant, X4 Pharmaceuticals' Current Assets surged by 18078.16% in 2023 and then plummeted by 5841.77% in 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Current Assets (Quarter) stood at $87.9 million in 2021, then surged by 46.43% to $128.7 million in 2022, then decreased by 5.13% to $122.1 million in 2023, then dropped by 8.11% to $112.2 million in 2024, then rose by 18.39% to $132.8 million in 2025.
  • Its Current Assets was $132.8 million in Q3 2025, compared to $72.9 million in Q2 2025 and $95.7 million in Q1 2025.